ask="N/A"
ask_size="N/A"
average_daily_volume="474470"
bid="55.00"
bid_size="4900"
book_value="11.38"
change="+1.47"
change_from_200_day_moving_average="5.87"
change_from_50_day_moving_average="4.09"
change_from_52_week_high="-10.53"
change_From_52_week_low="29.72"
change_in_percent="+1.97%"
close="76.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="76.34"
high_52_weeks="86.77"
last_trade_date="2/14/2017"
last_trade_price="76.24"
last_trade_size="20316"
last_trade_time="4:00pm"
low="73.91"
low_52_weeks="46.52"
market_capitalization="3.12B"
moving_average_200_day="70.37"
moving_average_50_day="72.15"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="74.68"
pe_ratio="N/A"
peg_ratio="-0.41"
percent_change_from_200_day_moving_average="+8.35%"
percent_change_from_50_day_moving_average="+5.67%"
percent_change_from_52_week_high="-12.14%"
percent_change_from_52_week_low="+63.89%"
previous_close="74.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.57"
price_per_sales="23867.40"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="284327"
weeks_range_52="46.52 - 86.77"
